QualTex Laboratories adds ISO/IEC 17025 accreditation for microbiology in San Antonio, Atlanta
QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global (BBG), has earned ISO/IEC 17025 accreditation from the ANSI National Accreditation Board for its microbiology testing laboratories in San Antonio and Atlanta. The accreditation demonstrates QualTex's commitment to quality and accuracy in its facilities. ISO/IEC 17025 is the international standard for competence in testing and calibration laboratories.
San Antonio, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global (BBG), has earned ISO/IEC 17025 accreditation from the ANSI National Accreditation Board for its microbiology testing laboratories in San Antonio and Atlanta.
Before earning ISO/IEC 17025 accreditation, QualTex had already achieved FDA registration, TGA and CLIA certifications for its microbiology testing laboratories, and ISO 9001:2015 certification for its quality management system.
“Earning this accreditation for our microbiology laboratories reflects our ongoing commitment to the world’s highest standards for testing laboratories,” said Geoffrey Kindt, Chief Operating Officer, QualTex Laboratories. “It signifies that we continue to provide the highest-quality testing results with best-in-class turnaround times.”
The QualTex laboratories in the San Antonio and Atlanta earned ISO/IEC 17025 for environmental monitoring, tissue sample sterility and bacterial identification. San Antonio’s microbiology testing laboratory is also accredited for bioburden and sterility testing.
The accreditation process includes an independent assessment of a laboratory's methods, personnel, equipment and quality management system against rigorous international standards. It is designed to ensure test results are accurate, reliable and reproducible.
Earning this accreditation demonstrates our commitment to providing fast, high-quality, microbiology testing services to clients around the globe,” said Martin Landon, Chief Executive Officer, BioBridge Global. “It’s a tribute to the hard work and dedication of our testing solutions teams in Texas and Georgia.”
QualTex Laboratories provides state-of-the-art biologic testing services on whole blood, plasma and human cells, tissue, and cellular- and tissue-based products for biotechnology and biopharmaceutical customers, as well as microbiology testing services, to support product safety and compliance in the biopharmaceutical, medical devices, tissue and cleanroom manufacturing industries. The microbiology laboratories produce consistent high-quality results through state-of-the-art automation and technical expertise.
Services include microbial detection, microbial qualification, microbial identification, environmental monitoring and more. QualTex is one of the nation’s largest nonprofit testing laboratories, and it features automated blood and plasma testing systems at its locations in Texas and Georgia.
###
About BioBridge Global: BioBridge Global is a San Antonio-based 501(c)(3) nonprofit healthcare services enterprise that offers diverse services through its nonprofit subsidiaries – South Texas Blood & Tissue, QualTex Laboratories, BBG Advanced Therapies and The Blood & Tissue Center Foundation. BioBridge Global provides products and services in blood resource management, cellular therapy, donated umbilical cord blood and human tissue, as well as testing of blood, plasma and tissue products for clients in the United States and worldwide. The enterprise enables advances in the field of regenerative medicine and advanced therapies by providing access to starting materials, testing services as well as biomanufacturing and clinical trials support. BioBridge Global is committed to saving and enhancing lives through the healing power of human cells and tissue. Learn more at BioBridgeGlobal.org.
Attachments
- QualTex Laboratories microbiology testing laboratory - Texas
- QualTex Laboratories microbiology testing laboratory - Georgia
David King BioBridge Global 210-731-5522 David.King@biobridgeglobal.org
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
